Vangl2 suppresses NF-κB signaling and ameliorates sepsis by targeting p65 for NDP52-mediated autophagic degradation

  1. Jiansen Lu
  2. Jiahuan Zhang
  3. Huaji Jiang
  4. Zhiqiang Hu
  5. Yufen Zhang
  6. Lian He
  7. Jianwu Yang
  8. Yingchao Xie
  9. Dan Wu
  10. Hongyu Li
  11. Ke Zeng
  12. Peng Tan
  13. Qingyue Xiao
  14. Zijing Song
  15. Chenglong Pan
  16. Xiaochun Bai  Is a corresponding author
  17. Xiao Yu  Is a corresponding author
  1. Department of Joint Surgery, the Fifth Affiliated Hospital, Southern Medical University, China
  2. Department of Immunology, School of Basic Medical Sciences, Southern Medical University, China
  3. Department of Clinical Laboratory Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, China
  4. Department of Orthopaedics, Yuebei People's Hospital Affiliated to Medical College of Shantou University, China
  5. Department of Pharmacology, School of Medicine, Southern University of Science and Technology, China
  6. Institute of Biosciences and Technology, College of Medicine, Texas A&M University, United States
  7. Klarman Cell Observatory, Broad Institute of MIT and Harvard, United States
  8. Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, China
  9. Guangdong Provincial Key Lab of Single Cell Technology and Application, Southern Medical University, China
9 figures and 5 additional files

Figures

Figure 1 with 1 supplement
Van Gogh-like 2 (Vangl2) ablation promotes inflammation during LPS treatment.

(A) Transcription levels of Vangl2 in PBMCs from healthy volunteers (healthy control, HC) and sepsis patients were analyzed by real-time PCR (n = 8). (B) Vangl2 mRNA in different organs from mice …

Figure 1—figure supplement 1
Expression of Van Gogh-like 2 (Vangl2) during sepsis and lipopolysaccharide (LPS) treatment.

(A) White blood cell (WBC) count, acute C-reactive protein (CRP), and IL-6 level in the peripheral blood mononuclear cell (PBMC) of healthy volunteers (HC) and sepsis patients (n ≥ 3). And WBC …

Figure 2 with 1 supplement
Van Gogh-like 2 (Vangl2) negatively regulates lipopolysaccharide (LPS)-induced NF-κB activation and proinflammatory cytokines.

Wild-type (WT) and Vangl2-deficient (n ≥ 3) pMAC (A, C) or neutrophils (B, D) were stimulated with LPS (100 ng/ml) for the indicated times. Immunoblot analysis of total and phosphorylated p65, …

Figure 2—figure supplement 1
Van Gogh-like 2 (Vangl2) defection promotes lipopolysaccharide (LPS)-induced NF-κB activation and production of inflammatory cytokines.

Volcano plot (A), gene ontology (GO) analysis (B), and KEGG analysis (C) of differentially expressed genes in wild-type (WT) and Vangl2-deficient bone marrow-derived macrophages (BMDMs) after LPS …

Figure 3 with 1 supplement
Van Gogh-like 2 (Vangl2) inhibits NF-κB signaling by interacting with p65.

Cho (A) or HEK293T cells (B, C) were co-transfected with a NF-κB and TK-Renilla reporter along with increasing amounts of Vangl2 for 18 hr, then treated the cells with or without lipopolysaccharide …

Figure 3—figure supplement 1
Van Gogh-like 2 (Vangl2) interacts with p65 to inhibit NF-κB activation.

Luciferase activity in HEK293T transfected with plasmids encoding an NF-κB luciferase reporter and TK-Renilla reporter, together with a vector encoding MyD88 (A), IRAK1 (B), TRAF6 (C), IKKα (D), …

Figure 4 with 1 supplement
Van Gogh-like 2 (Vangl2) promotes the autophagic degradation of p65.

(A) Immunoblot analysis of HEK293T cells transfected with Flag-p65 and increasing amounts of the vector encoding HA-Vangl2 (0, 250, 500, and 1000 ng) (n ≥ 3). (B) Total RNA from HEK293T cells as in …

Figure 4—figure supplement 1
Van Gogh-like 2 (Vangl2) promotes p65 degradation by autophagic pathway.

(A) Immunoblot analysis of HEK293T cells transfected with HA-p65 (wild-type [WT] or S536A) and Flag-Vangl2. (B) Immunoblot analysis of HEK293T cells transfected with HA-p65 and Flag-Vangl2 …

Figure 5 with 1 supplement
Van Gogh-like 2 (Vangl2) enhances the recognition of p65 by cargo receptor NDP52.

(A) HEK293T cells transfected with a vector expressing HA-Vangl2 along with the empty vector or vector encoding Flag-p62/NDP52/NBR1/Nix. The cell lysates were subjected to immunoprecipitation with …

Figure 5—figure supplement 1
Van Gogh-like 2 (Vangl2) promoted autophagic degradation of p65 is not mediated by cargo receptor p62.

(A) Wild-type (WT) and p62 knockout (KO) HEK293T cells transfected with a vector expressing HA-p65 along with the empty vector or vector encoding Flag-Vangl2. The cell lysates were subjected to …

Van Gogh-like 2 (Vangl2) increases the K63-linked ubiquitination of p65.

(A) Wild-type (WT) and Vangl2-deficient bone marrow-derived macrophages (BMDMs) were stimulated with lipopolysaccharide (LPS) (100 ng/ml) for the indicated times. The cell lysates were subjected to …

Figure 7 with 1 supplement
Van Gogh-like 2 (Vangl2) recruits PDLIM2 to ubiquitinate p65.

(A) HEK293T cells were transfected with the indicated small interfering RNA (siRNA), NF-κB reporter plasmids together with HA-Vangl2, Flag-p65, or the control vector as indicated for 24 hr, and then …

Figure 7—figure supplement 1
Expression of candidate E3 ubiquitin ligases in wild-type (WT) and Van Gogh-like 2 (Vangl2)-deficient bone marrow-derived macrophages (BMDMs) after lipopolysaccharide (LPS) treatment.

(A) Heatmap view of mRNA variations of E3 ubiquitin ligases in WT and Vangl2-deficient BMDMs treated with or without LPS. mRNA levels of Pdlim2 (B), Usp7 (C), and Trim21 (D) in the spleens from …

Author response image 1
Vangl2 degrades p65 through a selective autophagic pathway, but not by the PCP pathway.

HEK293T cells were transfected with Flag-p65 and HA-Vangl2 plasmids, and treated with DMSO, CQ (50 mM) for 6 h, SP600125 (20 mM) for 1 h or FH535 (30 mM) for 6 h. The cell lysates were analyzed by …

Author response image 2
Vangl2 deficiency promotes NF-kB activation.

(A) The survival rates of WT, Vangl2ΔM/ΔM and Vangl2ΔM/WT mice treated with high-dosage of LPS (30 mg/kg, i.p.) (n≥4). (B) IL-6 and TNF-a secretion by WT and Vangl2-deficient BMDMs treated with LPS …

Additional files

Supplementary file 1

Reagents and antibodies used in this study.

https://cdn.elifesciences.org/articles/87935/elife-87935-supp1-v1.docx
Supplementary file 2

Primers sequences for quantitative real-time reverse transcription polymerase chain reaction (RT-PCR) .

https://cdn.elifesciences.org/articles/87935/elife-87935-supp2-v1.docx
Supplementary file 3

Primers sequences for siRNA transfection.

https://cdn.elifesciences.org/articles/87935/elife-87935-supp3-v1.docx
Supplementary file 4

The sepsis patients’ information was shown in this study.

https://cdn.elifesciences.org/articles/87935/elife-87935-supp4-v1.docx
MDAR checklist
https://cdn.elifesciences.org/articles/87935/elife-87935-mdarchecklist1-v1.docx

Download links